Cargando…
Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin
BACKGROUND: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA)...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023929/ https://www.ncbi.nlm.nih.gov/pubmed/24837459 http://dx.doi.org/10.1371/journal.pone.0096658 |
_version_ | 1782316588767117312 |
---|---|
author | Matheson, Alastair I. Manhart, Lisa E. Pavlinac, Patricia B. Means, Arianna R. Akullian, Adam Levine, Gillian A. Jacobson, Julie Shutes, Erin Walson, Judd L. |
author_facet | Matheson, Alastair I. Manhart, Lisa E. Pavlinac, Patricia B. Means, Arianna R. Akullian, Adam Levine, Gillian A. Jacobson, Julie Shutes, Erin Walson, Judd L. |
author_sort | Matheson, Alastair I. |
collection | PubMed |
description | BACKGROUND: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA) of azithromycin (AZM) prompted the development of visually compelling, easy-to-use tools that synthesize country-specific data on factors that would influence both potential AZM benefit and MDA implementation success. METHODOLOGY/PRINCIPAL FINDINGS: We assessed the opportunity to reduce mortality and the feasibility of implementing such a program, creating Opportunity and Feasibility Indices, respectively. Countries with high childhood mortality were included. A Country Ranking Index combined key variables from the previous two Indices and applied a scoring system to identify high-priority countries. We compared four scenarios with varying weights given to each variable. Twenty-five countries met inclusion criteria. We created easily visualized tools to display the results of the Opportunity and Feasibility Indices. The Opportunity Index revealed substantial variation in the opportunity for an MDA of AZM program to reduce mortality, even among countries with high overall childhood mortality. The Feasibility Index demonstrated that implementing such a program would be most challenging in the countries that could see greatest benefit. Based on the Country Ranking Index, Equatorial Guinea would benefit the most from the MZA of AZM in three of the four scenarios we tested. CONCLUSIONS/SIGNIFICANCE: These visually accessible tools can be adapted or refined to include other metrics deemed important by stakeholders, and provide a quantitative approach to prioritization for intervention implementation. The need to explicitly state metrics and their weighting encourages thoughtful and transparent decision making. The objective and data-driven approach promoted by the three Indices may foster more efficient use of resources. |
format | Online Article Text |
id | pubmed-4023929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40239292014-05-21 Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin Matheson, Alastair I. Manhart, Lisa E. Pavlinac, Patricia B. Means, Arianna R. Akullian, Adam Levine, Gillian A. Jacobson, Julie Shutes, Erin Walson, Judd L. PLoS One Research Article BACKGROUND: As new interventions to reduce childhood mortality are identified, careful consideration must be given to identifying populations that could benefit most from them. Promising reductions in childhood mortality reported in a large cluster randomized trial of mass drug administration (MDA) of azithromycin (AZM) prompted the development of visually compelling, easy-to-use tools that synthesize country-specific data on factors that would influence both potential AZM benefit and MDA implementation success. METHODOLOGY/PRINCIPAL FINDINGS: We assessed the opportunity to reduce mortality and the feasibility of implementing such a program, creating Opportunity and Feasibility Indices, respectively. Countries with high childhood mortality were included. A Country Ranking Index combined key variables from the previous two Indices and applied a scoring system to identify high-priority countries. We compared four scenarios with varying weights given to each variable. Twenty-five countries met inclusion criteria. We created easily visualized tools to display the results of the Opportunity and Feasibility Indices. The Opportunity Index revealed substantial variation in the opportunity for an MDA of AZM program to reduce mortality, even among countries with high overall childhood mortality. The Feasibility Index demonstrated that implementing such a program would be most challenging in the countries that could see greatest benefit. Based on the Country Ranking Index, Equatorial Guinea would benefit the most from the MZA of AZM in three of the four scenarios we tested. CONCLUSIONS/SIGNIFICANCE: These visually accessible tools can be adapted or refined to include other metrics deemed important by stakeholders, and provide a quantitative approach to prioritization for intervention implementation. The need to explicitly state metrics and their weighting encourages thoughtful and transparent decision making. The objective and data-driven approach promoted by the three Indices may foster more efficient use of resources. Public Library of Science 2014-05-16 /pmc/articles/PMC4023929/ /pubmed/24837459 http://dx.doi.org/10.1371/journal.pone.0096658 Text en © 2014 Matheson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Matheson, Alastair I. Manhart, Lisa E. Pavlinac, Patricia B. Means, Arianna R. Akullian, Adam Levine, Gillian A. Jacobson, Julie Shutes, Erin Walson, Judd L. Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin |
title | Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin |
title_full | Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin |
title_fullStr | Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin |
title_full_unstemmed | Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin |
title_short | Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin |
title_sort | prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023929/ https://www.ncbi.nlm.nih.gov/pubmed/24837459 http://dx.doi.org/10.1371/journal.pone.0096658 |
work_keys_str_mv | AT mathesonalastairi prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT manhartlisae prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT pavlinacpatriciab prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT meansariannar prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT akullianadam prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT levinegilliana prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT jacobsonjulie prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT shuteserin prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin AT walsonjuddl prioritizingcountriesforinterventionstoreducechildmortalitytoolsformaximizingtheimpactofmassdrugadministrationofazithromycin |